Optimal duration of dual antiplatelet therapy after implantation of bioresorbable vascular scaffolds: lessons from optical coherence tomography

Katsumasa Sato, Vasileios F. Panoulas, Toru Naganuma, Tadashi Miyazaki, Azeem Latib, Antonio Colombo

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The current case report demonstrates the interesting finding of incomplete bioresorbable vascular scaffold (BVS) strut coverage at 18 months after implantation for a chronic total occlusion of the left anterior descending coronary artery. In this case, local differences in shear stress could explain the simultaneous presence of well covered and uncovered BVS strut segments in the same optical coherence tomography frame. Even though current standard practice suggests dual antiplatelet therapy for 12 months after BVS implantation, further studies are required to establish optimal duration of dual antiplatelet therapy, particularly when tackling complex lesions.

Original languageEnglish
JournalCanadian Journal of Cardiology
Volume30
Issue number11
DOIs
Publication statusPublished - Nov 1 2014

Fingerprint

Optical Coherence Tomography
Blood Vessels
Coronary Vessels
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Optimal duration of dual antiplatelet therapy after implantation of bioresorbable vascular scaffolds : lessons from optical coherence tomography. / Sato, Katsumasa; Panoulas, Vasileios F.; Naganuma, Toru; Miyazaki, Tadashi; Latib, Azeem; Colombo, Antonio.

In: Canadian Journal of Cardiology, Vol. 30, No. 11, 01.11.2014.

Research output: Contribution to journalArticle

Sato, Katsumasa ; Panoulas, Vasileios F. ; Naganuma, Toru ; Miyazaki, Tadashi ; Latib, Azeem ; Colombo, Antonio. / Optimal duration of dual antiplatelet therapy after implantation of bioresorbable vascular scaffolds : lessons from optical coherence tomography. In: Canadian Journal of Cardiology. 2014 ; Vol. 30, No. 11.
@article{2b1fc5573b0a4033aaa480637146b9ef,
title = "Optimal duration of dual antiplatelet therapy after implantation of bioresorbable vascular scaffolds: lessons from optical coherence tomography",
abstract = "The current case report demonstrates the interesting finding of incomplete bioresorbable vascular scaffold (BVS) strut coverage at 18 months after implantation for a chronic total occlusion of the left anterior descending coronary artery. In this case, local differences in shear stress could explain the simultaneous presence of well covered and uncovered BVS strut segments in the same optical coherence tomography frame. Even though current standard practice suggests dual antiplatelet therapy for 12 months after BVS implantation, further studies are required to establish optimal duration of dual antiplatelet therapy, particularly when tackling complex lesions.",
author = "Katsumasa Sato and Panoulas, {Vasileios F.} and Toru Naganuma and Tadashi Miyazaki and Azeem Latib and Antonio Colombo",
year = "2014",
month = "11",
day = "1",
doi = "10.1016/j.cjca.2014.07.006",
language = "English",
volume = "30",
journal = "Canadian Journal of Cardiology",
issn = "0828-282X",
publisher = "Pulsus Group Inc.",
number = "11",

}

TY - JOUR

T1 - Optimal duration of dual antiplatelet therapy after implantation of bioresorbable vascular scaffolds

T2 - lessons from optical coherence tomography

AU - Sato, Katsumasa

AU - Panoulas, Vasileios F.

AU - Naganuma, Toru

AU - Miyazaki, Tadashi

AU - Latib, Azeem

AU - Colombo, Antonio

PY - 2014/11/1

Y1 - 2014/11/1

N2 - The current case report demonstrates the interesting finding of incomplete bioresorbable vascular scaffold (BVS) strut coverage at 18 months after implantation for a chronic total occlusion of the left anterior descending coronary artery. In this case, local differences in shear stress could explain the simultaneous presence of well covered and uncovered BVS strut segments in the same optical coherence tomography frame. Even though current standard practice suggests dual antiplatelet therapy for 12 months after BVS implantation, further studies are required to establish optimal duration of dual antiplatelet therapy, particularly when tackling complex lesions.

AB - The current case report demonstrates the interesting finding of incomplete bioresorbable vascular scaffold (BVS) strut coverage at 18 months after implantation for a chronic total occlusion of the left anterior descending coronary artery. In this case, local differences in shear stress could explain the simultaneous presence of well covered and uncovered BVS strut segments in the same optical coherence tomography frame. Even though current standard practice suggests dual antiplatelet therapy for 12 months after BVS implantation, further studies are required to establish optimal duration of dual antiplatelet therapy, particularly when tackling complex lesions.

UR - http://www.scopus.com/inward/record.url?scp=84964313211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964313211&partnerID=8YFLogxK

U2 - 10.1016/j.cjca.2014.07.006

DO - 10.1016/j.cjca.2014.07.006

M3 - Article

C2 - 25442445

AN - SCOPUS:84908483413

VL - 30

JO - Canadian Journal of Cardiology

JF - Canadian Journal of Cardiology

SN - 0828-282X

IS - 11

ER -